NCT01658774View on ClinicalTrials.gov

Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children

NACompletedINTERVENTIONAL
Enrollment

2,377

Participants

Timeline

Start Date

January 31, 2013

Primary Completion Date

January 31, 2015

Study Completion Date

January 31, 2015

Conditions
Intestinal HelminthiasisAscariasisHookwormMalaria
Interventions
DRUG

Albendazole

Single 400mg dose

DIETARY_SUPPLEMENT

Vitamin C

500 mg Vitamin C

Trial Locations (1)

P.O. Box 43640 - 00100

KEMRI-Wellcome Trust Programme, Nairobi

All Listed Sponsors
collaborator

European Union

OTHER

collaborator

Wellcome Trust

OTHER

lead

London School of Hygiene and Tropical Medicine

OTHER

NCT01658774 - Impact of Repeated Anthelmintic Treatment on the Risk of Malaria in Kenyan School Children | Biotech Hunter | Biotech Hunter